X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3677) 3677
Publication (158) 158
Book Chapter (62) 62
Book Review (55) 55
Government Document (11) 11
Conference Proceeding (8) 8
Dissertation (8) 8
Book / eBook (6) 6
Magazine Article (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
emesis (2018) 2018
humans (1888) 1888
male (1420) 1420
female (1340) 1340
nausea (1110) 1110
vomiting - chemically induced (1096) 1096
oncology (1047) 1047
antiemetics - therapeutic use (936) 936
chemotherapy (928) 928
ondansetron (892) 892
vomiting - prevention & control (881) 881
pharmacology & pharmacy (837) 837
index medicus (809) 809
animals (803) 803
adult (801) 801
middle aged (797) 797
vomiting (769) 769
nausea - chemically induced (738) 738
prevention (699) 699
antineoplastic agents - adverse effects (686) 686
double-blind (669) 669
cisplatin-induced emesis (649) 649
nausea - prevention & control (603) 603
induced emesis (593) 593
aged (576) 576
cisplatin (571) 571
dexamethasone (542) 542
cancer (497) 497
vomiting - drug therapy (432) 432
metoclopramide (409) 409
antiemetics - administration & dosage (389) 389
antiemetics (388) 388
double-blind method (384) 384
granisetron (360) 360
efficacy (353) 353
neoplasms - drug therapy (345) 345
nausea - drug therapy (333) 333
cisplatin - adverse effects (309) 309
dose-response relationship, drug (305) 305
adolescent (297) 297
ondansetron - therapeutic use (297) 297
delayed emesis (293) 293
anesthesiology (290) 290
prospective studies (288) 288
induced nausea (280) 280
rats (274) 274
treatment outcome (272) 272
child (271) 271
drug therapy, combination (268) 268
health care sciences & services (266) 266
high-dose metoclopramide (264) 264
antiemetics - pharmacology (261) 261
chemotherapy-induced nausea (254) 254
medicine & public health (253) 253
prophylaxis (252) 252
neurosciences (250) 250
5-ht (241) 241
rehabilitation (237) 237
moderately emetogenic chemotherapy (235) 235
antiemetics - adverse effects (225) 225
aprepitant (214) 214
serotonin antagonists - therapeutic use (212) 212
vomiting - etiology (211) 211
dexamethasone - therapeutic use (210) 210
receptor antagonist (208) 208
serotonin (207) 207
area postrema (206) 206
antineoplastic combined chemotherapy protocols - adverse effects (201) 201
cancer-chemotherapy (197) 197
ferret (197) 197
antagonist (193) 193
child, preschool (191) 191
time factors (190) 190
nursing (179) 179
children (178) 178
analysis (174) 174
medicine, general & internal (172) 172
gastrointestinal agents (171) 171
postoperative nausea (171) 171
dexamethasone - administration & dosage (167) 167
antiemetic (163) 163
pediatrics (163) 163
aged, 80 and over (162) 162
pain medicine (160) 160
administration, oral (157) 157
surgery (157) 157
vomiting - physiopathology (157) 157
care and treatment (156) 156
ondansetron - administration & dosage (156) 156
placebo-controlled trial (154) 154
antineoplastic agents - therapeutic use (147) 147
ferrets (147) 147
nausea - etiology (147) 147
anesthesia (143) 143
therapy (141) 141
tropisetron (141) 141
droperidol (140) 140
serotonin antagonists - pharmacology (140) 140
chemotherapy-induced nausea and vomiting (139) 139
injections, intravenous (138) 138
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3507) 3507
German (102) 102
French (60) 60
Japanese (39) 39
Spanish (25) 25
Italian (5) 5
Korean (5) 5
Czech (4) 4
Turkish (4) 4
Polish (3) 3
Portuguese (3) 3
Icelandic (2) 2
Hungarian (1) 1
Indonesian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmacology, ISSN 0014-2999, 01/2014, Volume 722, Issue 1, pp. 13 - 25
The concept that 5-hydroxytryptamine (5-HT; serotonin) is involved in the emetic reflex was revealed using drugs that interfere with its synthesis, storage,... 
Serotonin | Anti-emesis | Emesis | Antiemetic | Vomit | Nausea, 5-HT | Nausea 5-HT | CHEMOTHERAPY-INDUCED NAUSEA | MOTION SICKNESS | POSSIBLE INVOLVEMENT | SUNCUS-MURINUS | HOUSE MUSK SHREW | AREA POSTREMA | DRUG-INDUCED EMESIS | ANTIEMETIC ACTIVITY | INDUCED DELAYED EMESIS | PHARMACOLOGY & PHARMACY | CISPLATIN-INDUCED EMESIS
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2017, Volume 28, Issue 6, pp. 1260 - 1267
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2011, Volume 67, Issue 3, pp. 667 - 686
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 06/2017, Volume 28, Issue 6, pp. 1260 - 1267
Background: Despite the availability of effective antiemetics and evidence-based guidelines, up to 40% of cancer patients receiving chemotherapy fail to... 
EUROPEAN EMESIS REGISTRY | GUIDELINE UPDATE | MASCC | VALIDATION | PREVENTION | emesis | LOGISTIC-REGRESSION ANALYSIS | MODEL | nausea | BREAST-CANCER | CINV | WOMEN | IMPACT | ONCOLOGY | prediction | risk | cancer | Young Adult | Vomiting - chemically induced | Nausea - chemically induced | Risk Assessment | Antineoplastic Agents - adverse effects | Humans | Middle Aged | Aged, 80 and over | Adult | Female | Male | Aged | Editor's Choice | Original
Journal Article
Behavioural Brain Research, ISSN 0166-4328, 04/2016, Volume 303, pp. 26 - 33
Enhancement of central availability of the second messenger cAMP is a promising approach to improve cognitive function. Pharmacological inhibition of... 
PDE4 inhibition | Rolipram | PDE4 | Memory | Cognition | Roflumilast | cAMP | Emesis | CAMP | TARGET | LONG-TERM-MEMORY | DEPENDENT MEMORY | NEUROSCIENCES | PHOSPHODIESTERASE INHIBITORS | IN-VITRO | ENHANCE | OBJECT RECOGNITION | BEHAVIORAL SCIENCES | SPATIAL MEMORY | Gastrointestinal agents | Rodents | Neurosciences | Lung diseases, Obstructive | Analysis | Cyclic adenylic acid | Drug approval
Journal Article